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Molecular Definition of a Narrow Interval at 7q22.1 
Associated With Myelodysplasia 
By E.J. Johnson, S.W. Scherer, L. Osborne, L.C. Tsui, D. Oscier, S. Mould, and F.E. Cotter 
Chromosome 7 translocations, deletions, or monosomy are 
associated with myelodysplasia (MDS) and acute myeloid 
leukemia both in children and adults. These chromosomal 
anomalies represent one of the most common cytogenetic 
abnormalities associated with these diseases and usually 
herald a poor prognosis. In this study two cosmid DNA 
probes that mapped to 7q22.1 and were known to be sepa- 
rated by approximately 500 kb were identified to flank the 
proximal inversion breakpoint in a patient carrying a consti- 
tutional inversion (7q22.1-34) associated with MDS. A yeast 
artificial chromosome (YAC) clone that encompassed the 
two cosmids was identified and shown to span the 
YELODYSPLASIA (MDS) has a bimodal age distri- M bution with peaks in the first and sixth decades. It is 
characterized by dysplastic and ineffective hematopoiesis 
and a tendency to progress to acute leukemia. The French- 
American-British (FAB) classification is used for the adult 
disease but is not as readily applicable in children because 
of specific conditions that do not clearly fit the FAB groups. 
These include juvenile chronic myeloid leukemia (JCML) 
and infant monosomy 7 syndrome (IMo7), which require 
certain clinical and cytogenetic features for diagnosis.’.’ 
Prognosis may be determined by a number of factors, partic- 
ularly in childhood MDS, such as platelet count, hemoglobin 
F (HbF) level, and cytogenetic complexity. 
A recent study showed that of 63 cases of childhood MDS 
in whom karyotype analysis was performed, 55% had clonal 
abnormalities affecting chromosome 7.’ Within this group, 
monosomy 7 seems to be more common than 7q deletions. 
A review of childhood monosomy 7 has clearly divided the 
myeloid disorders associated with monosomy 7 into three 
groups: de novo disorders (MDS, acute myeloid leukemia 
[AML], monosomy 7 syndrome, and JCML), secondary dis- 
orders (therapy-related, occupational exposure and severe 
aplastic anaemia), and constitutional disorders (Fanconi’s 
anemia, Kostmann’s syndrome, Shwachman’s syndrome, 
Neurofibromatosis type 1, Down syndrome, and familial mono- 
somy 7): However, JCML is distinct in that it is very rarely 
associated with chromosome 7 abnormalities, even at the 
submicroscopic level. 
Loss of heterozygosity of chromosome 7 as determined 
using polymorphic probes on material from patients with 
MDSlAML with no detectable cytogenetic abnormality is 
very ~ncommon.~  There is a male predominance in de novo 
disorders and Shwachman’s syndrome but a more equal sex 
incidence in Kostmann’s syndrome and familial monosomy 
7.4 Treatment of these diseases is generally difficult, although 
chemotherapy can delay the advancement of disease in some 
instances. However, progression to acute leukemia with mo- 
nosomy 7 is extremely difficult to treat, with few successes 
after bone marrow transplantation (BMT): 
A tumor-suppressor gene model’.’ has been proposed, but 
it is not known if the loss of function of only one allele 
breakpoint. Fluorescence in situ hybridization was then used 
to analyze six additional patients with myelodysplasia and 
chromosomal rearrangements of the 7q22 region (three pa- 
tients had translocations and three carried deletions). The 
breakpoint in one of the patients was found to be contained 
within the same YAC clone that spanned the inversion 
breakpoint. Moreover, this same interval was determined to 
be absent in all three patients with chromosomal deletions. 
These results suggest that this segment of DNA on chromo- 
some 7q22.1 may contain specific gene(s) that have a sig- 
nificant role in myeloid malignancies. 
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(haploinsufficiency) is needed to cause disease.’ Most evi- 
dence suggests that chromosome 7 loss is necessary but not 
sufficient for disease and is a relatively late event in disease 
progression. This applies to both adult and childhood dis- 
ease. No candidate gene has yet been identified on chromo- 
some 7. Cytogenetic studies suggest as “critical regions” a 
commonly involved DNA segment in band 7q22 and less 
commonly another at 7q32-34.’.I0 Restriction fragment 
length polymorphism (FWLP) and pulsed-field analysis has 
been used in an attempt to define deletions in adults with 
MDS/AML and 7q deletions [termed del(7q)].”-’3 These ex- 
perimental approaches may be problematic because the chro- 
mosomally abnormal cells (which are sometimes present in 
relatively low numbers) are often mixed in with normal cells. 
Notwithstanding, the proximal 7q22 breakpoints could be 
located between the genes for erythropoietin (EPO) and plas- 
minogen activator inhibitor 1 (PLANHI) in four patients in 
one study” and three patients in a n ~ t h e r ’ ~  (Fig 1). In the 
latter study, breakpoints for two additional patients were 
positioned between elastin (ELN) and collagen 1 a 2 
(COL1A2)I3 (Fig 1). The critical region of deletion within 
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Prepcirafion of metaphase spreads. The unsynchronized BM 
cultures and DD1027 cell line cultures were arrested at metaphase 
by the addition of colcemid (0.5 pg/mL) for 45 minutes and the 
cells were fixed in 3:l methano1:glacial acetic acid. Cells were 
dropped onto glass slides that were then kept at least 24 hours before 
use. Metaphase chromosomes were banded by standard G-banding 
with trypsin-Giemsa (GTG)'" and karyotyped according to the Inter- 
national System for Human Cytogenetic Nomenclature. For FISH. 
slides were washed in 2 X standard saline citrate (SSC) for 1 hour, 
denatured in 70% formamide at 70°C for 2 minutes. then dried in 
70%. 85%. and 100% ethanol, at room temperature, 3 minutes in 
each. 
FISH analvsis. The cosmids and YACs (see Table I )  were 
grown in appropriate conditions and DNA was prepared using stan- 
dard procedures and purified using RNase and phenolkhloroform 
extraction. One microgram of cosmid or YAC DNA per sample was 
nick-translated with biotin-14-dATP. using the Bionick Labelling 
System (GIBCO BRL, Paisley, UK). Probe was also prepared by 
Ah-PCR as described." Both methods of probe preparation gave 
comparable results. Cot-I DNA (GIBCO BRL) was added to bind 
repetitive sequences. A digoxigenin-labeled a satellite chromosome 
7 centromere probe (Oncor) and in three cases a biotin-labeled CY 
satellite chromosome 2 probe (Oncor, Gaithersburg, MD) (patients 
A, B, and C)  were added before the labeled cosmids were hybridized 
to chromosome DNA overnight at 37°C in a humid chamber. Posthy- 
bridization washing was performed in 50% formamide, 2 X SSC, 
X 3 and 2 X SSC X 3 all at 42°C for 5 minutes each. Signal detection 
was achieved using fluorescein isothiocyanate (F1TC)-conjugated to 
avidin and biotinylated antiavidin antibody (Vector Laboratories. 
Burlingame. CA). Antidigoxigenin rhodamine was added with the 
first FlTC layer to detect chromosome 7 centromeres. Slides were 
then stained with DAPl and viewed using a Zeiss Axiophot epifluo- 
rescence microscope (Carl Zeiss Mikroskop-System, Oberkochen, 
Germany) with a cooled charge-coupled device (CCD) camera 
(Astromed, Cambridge, UK) and the IPLabs software supplied by 
Digital Scientific (Cambridge, UK). At least 15 metaphases per sam- 
ple/slide were viewed. 
The YAC clones were isolated from a 
chromosome 7-specific library" as were the cosmids; the latter 
being from the Lawrence Livermore National Laboratory (Berkley, 
CA). The presence or absence of DNA markers within each genomic 
clone has been published previously"."' or is described for the first 
time in this study. The insert size of the YAC clones was determined 
by pulsed-field gel electrophoresis followed by comparison to 
YPH149 size standards." Specific information on each of the DNA 
markers is available in the Genome Database (Cambridge, UK). 
YAC and cosmid clones. 
n 
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Fig 1. Chromosome 7 with (left): position of breakpoint in DD1027 
cell line and relative positions of breakpoints in translocation patients 
A, B, and C (Table 2). and (right): positions of breakpoints as reported 
in RFLP studies by 'Kere et al, 1989" and by **Lewis et al, 1993." 
7q32-qter occurred proximal to the T-cell receptor gene 
at 7q3S in two patients and proximal to the anonymous 
marker D7S 104 at 7q36-qter in five patients." 
The introduction of fluorescence in situ hybridization 
(FISH) has allowed for more accurate analyses of rearrange- 
ments at the cytogenetic and molecular level.14 We have 
applied this approach to try to clarify further the nature of 
the chromosome changes in MDS and AML. Translocations 
and inversions affecting the region of interest are less com- 
mon in MDS but may provide a more accessible means 
of identifying putative causative genes than monosomy of 
chromosome 7 and larger deletion samples. FISH with chro- 
mosome 7-specific yeast artificial chromosomes (YACs) 
and cosmids from the q2 1-22 bands was used to analyze and 
localize such breakpoint regions. 
MATERIALS AND METHODS 
Cell line ond hone marrow (RM) samples. The Epstein-Barr 
virus transformed lymphoblastoid cell line DD1027 was obtained 
from ECACC (Salisbury, UK). Culture was at 37°C and 6% carbon 
dioxide in RPMI, 10% fetal calf serum, with added glutamine, strep- 
tomycin, and tetracycline. A cell concentration of between 0.5 and 
2.0 X 10" was maintained. BM samples were collected in heparin 
tubes and cultured at 37°C in RPMI 1640 supplemented with 10% 
5637 conditioned medium" and a concentration of 10" cellslml. 
RESULTS 
Ident$cafion of a family segregating a 7q22.1 inversion 
breakpoint. A lymphoblastoid cell line, DD 1027 derived 
from a patient with a constitutional inversion, 46XY 
inv7q22.1-34 as the sole cytogenetic abnormality was stud- 
ied (Fig 2). The patient was phenotypically normal; however, 
further family cytogenetic analysis showed IO members of 
IS with the same constitutional rearrangement (Fig 3) and 
2 cases of hematologic abnormality. An uncle of this patient 
developed myelodysplasia as a child and has subsequently 
died after a BMT. An aunt in her early 40s currently has 
pancytopaenia and BM changes consistent with MDS. Both 
possessed the inversion. No other members of the family 
had any evidence of hematologic anomaly and there was no 
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Table 1. Hybridization Position of Probes Relative to Breakpoint on Inversion Chromosome 7 on DD1027 Cell Line 146XY invf7)fq22.1-34)1 
DNA Markers Contained Hybridization 
Probe Size Location in Clone Position 
Cosmid 4b.l 
Cosmid 5.1 
Cosmid 5.2 
Cosmid 7b.l  
Cosmid 524 
Cosmid 7c.l 
Cosmid 7d.l 
Cosmid 7d.2 
Cosmid 8a.l 
Cosmid 8a.2 
Cosmid 8a.3 
Cosmid 8b.l 
Cosmid 9.1 
Cosmid 10.2 
Cosmid 10.3 
7q21.1-21.3 
7q21.3 
7q21.3 
7q21.3 
7q21.3 
7q22.1 
7q22 
7q22 
7q22 
7q22 
7q22 
7q22 
7q22 
7q22-31 
7q22-31 
D7S574 
D7S15 
D7S64 
E1131M30 
DLX5 
ASNS 
932d8.2 
GNB2 
ACHE 
PLANHl 
CUTLl 
D7S238 
LAMB1 
D7S148 
YAC HSC7E800 
YAC HSC7E1131 
580 kb 
1160 kb 
7q21.3-22.1 DLX5, DLXG 
7q21.3-22.1 DLX5, DLXG 
D7S491, D7S811 
D7S479. D7S491 
D7S811, D7S821 
AFM088ye9, D7S1796 
D7S554 
YAC HSC7E783 650 kb 7q21.3-22.1 ASNS, D7S82 
YAC HSC7E1214 980 kb 7q21.3-22.1 ASNS, TAC2 
Proximal 
Proximal 
Proximal 
Proximal 
Proximal 
Distal 
Distal 
Distal 
Distal 
Distal 
Distal 
Distal 
Distal 
Distal 
Distal 
Proximal 
Proximal 
Across 
D7S82, D7S554 Distal 
n 
11 I I 
21 m 
Fig 2. Idiogram and G-banded images showing 
normal chromosome 7 and inversion 7q22.1-34. INVERSION 
n 
11 
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22.2 
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Fig 3. Family tree to show members affected by constitutional 
inversion 7q22.1-34. 
history of occupational or environmental exposure to carcin- 
ogens. 
Characterisation of the proximal end of a constitutional 
inversion 7q22.I-q34 associated with MDS. Fifteen cos- 
mids previously localized and ordered in relationship to each 
other on band 7q22" were hybridized by FISH onto meta- 
phase spreads from the cell line DD 1027 together with a 
centromeric chromosome 7 probe. The results are summa- 
rised in Table I .  The proximal inversion breakpoint was 
shown to occur between cosmid 524, which is located in its 
expected position at 7q21.3, and cosmid 7c. I ,  which hybrid- 
izes in the distal position at 7q34 on the inversion chromo- 
some [see (Fig 5a.i) and 5b.i)l. Cosmid 524 has previously 
been mapped centromeric to cosmid 7c. 12* and they were 
the two closest flanking markers available, being separated 
by approximately 500 kb (Fig 4). Cosmid 7c. 1 was identified 
with an asparagine synthetase (ASNS) gene probe (Table 
Four  YAC  clones  (HSC7E800, HSC7EI131, HSC7E1214, 
HSC7E783) from a contig spanning the region between cos- 
mids 524 and 7c.I2" (Fig 4) were mapped by FISH against 
the cell line DD 1027. YAC HSC7E800 and HSC7E1131 
were found, as expected, to be centromeric to the proximal 
breakpoint at 7q22 and HSC7E1214 mapped  in  the inverted 
position  on the rearranged chromosome. HSC7E783 crossed 
the breakpoint as split hybridization signals were observed 
at two positions on the long arm of the inversion chromo- 
some (Fig 5c). All four YACs hybridized to the expected 
position on the normal chromosome 7 in the DD 1027 cell 
line and  on  normal  human metaphase chromosomes [(Fig 5 
1).23 
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a.ii), b.ii). c.ii)]. A search for genes in this  region  has  been 
initiated and one previously cloned  gene. ASNS, was  found 
to  map  within HSC7E783.23 
Localization of additional breakpoints associated with 
MDS. Cells from three additional adult patients with MDS 
associated with translocations involving 7q22 (Table 2)  were 
examined with  YAC  HSC7E783. FISH showed a consistent 
split hybridization signal on both the derivative 2 and 7 
chromosomes in cells from patient B and a single hybridiza- 
tion to the normal chromosome 7 and none to the normal 
chromosome 2 (Fig 6, black and white panels). However. 
the hybridization of YAC HSC7E783 to the derivative 7 
chromosome takes  place at 7p. The long  arm  of this chromo- 
some is also abnormal and  more complex than  the  karyotype 
reveals. The FISH results suggest a complex  rearrangement 
of the abnormal chromosome 7. The splitting of the YAC 
signal remains consistent between chromosomes 7 and 2 
(with hybridization at the  predicted site on the latter) as well 
as showing signal at 7q22.1 on the normal chromosome 7 
demonstrating the single copy  specificity of the probe  to this 
region on the long arm. This indicates that in this patient 
the chromosomal rearrangement involves the same 500-kb 
region of chromosome 7 as the proximal  inversion 
breakpoint in the  DD1027 cell line. The breakpoints in pa- 
tients A and C were found  to be proximal  and distal. respec- 
GENES YACs COSMIDS 
HSC7E1131 
q 21.3 
q 22.1 
HSC7E1214 
Fig 4. Position  of  cosmids, YAC contig, and genes at 7q22. 
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Table 2. Patients with Disease and Karyotype 
Patient Phenotype ~ W O t y p s  
A: MD 5/1/95 MDS 46, XY, t(2;7)(pll;q22) 
B: MD s13/95 MDS 46, XY, t(2;7)(pll;q21.2) 
C MD 5/2/95 MDS 46. XX. t(2;7)(pll;q22), deI(7) 
(q34q36). der(8) t(8;12)(p21;qll) 
D: MD SI4195 MDS-RARS 46, XY, &1(7)(qZZq32) 
E: A M W 5  AML 46. XY. de1(7)(q22q31) 
F AMt/6195 AML 46-47. XY, -2, -4, de1(5)(q23q33) del 
(7)(q22). +2-3r, +2-4 mar 
Lymphoblsstoid MDS 46. XY. inv (7)(q22.lq34) 
cell line, 
DD1027 
tively, to HSC7E783 (Fig 6, patients A and C, Table 2). 
The exact position of the translocation breakpoints in these 
patients is currently being determined. 
Another three adult patients with 7q22 
deletions associated with MDS were identified (Table 2) and 
BMs examined by FISH with YAC HSC7E783. In all three 
the hybridization signal was consistently present on the nor- 
mal, but absent on the abnormal chromosome 7 (Fig 7, Table 
2). 
Deletion in 7q-. 
DISCUSSION 
The results of this study define a narrow region at 7q22.1 
within which a chromosomal rearrangement from two unre- 
lated patients with MDS resides. Examination of patients 
with MDS and deletions of 7q22 with a YAC clone 
(HSC7E783) that encompassed the breakpoint region indi- 
cated that this interval is also commonly lost in del(7q) 
patients. These observations are consistent and this region 
of the chromosome is located in the same general proximal 
“critical region” as established in other studies (see Fig 1). 
However, two of the patients with translocations and MDS 
show a heterogeneity in the position of their breakpoints 
although still located within the 7q22 band. Loss of heterozy- 
gosity at 7q22 in myeloid disorders, as determined by RFLP 
studies, has been demonstrated previously.’z Our findings 
are in keeping with this data; however, a similar studyI3 on 
five patients suggests there may also be a more distal 
breakpoint region within 7q22. It is probable that more than 
one region of chromosome 7q22 contributes to the same type 
of disease as seen with adults with MDS and 5q-= and 
suggested by the two translocation patients (A and C). It is 
possible that the breakpoint region identified in our study 
contains a gene that plays a role in inducing h4DS and AML. 
ASNS has been mapped to YAC HSC7E783.= The cos7c.l 
probe used in the FISH study was identified using the ASNS 
cDNA probe and this cosmid was found to be distal to the 
inversion breakpoint, suggesting that the rearrangement did 
not directly interrupt this gene. The exact distance of ASNS 
from the breakpoint has not been detennined, but based on 
the size of HSC7E783 (650 kb) it cannot be more than a 
few hundred kilobases away. 
ASNS is a cell-cycle control enzymez6 and as such it is 
being examined as a candidate gene for MDS in these pa- 
tients. Expression of abnormally low levels of this gene have 
k n  reported in AML,2’ further adding to speculation that 
loss of function of this gene could contribute to the pathogen- 
esis of MDS and AML associated with 7q22.1 rearrange- 
ment. A tumor-suppressor gene model could be considered 
as a mechanism of disease and, if so, it could be postulated 
that a translocation would render one copy of the gene dys- 
functional (either by direct disruption of the gene or through 
a “position effect”). In the case of monosomy 7 and del 
(7q), one copy would be lost, whereas the remaining copy 
of the gene may be inactivated by mutation or methyla- 
tion.28.29 This would suggest in the family with the constitu- 
tional inversion that such an alteration on the remaining 
chromosome 7 led to the development of MDS and pancyto- 
penia in the two affected family members. Similar changes 
to the remaining chromosome 7 in monosomy or 7q- would 
have the same effect. 
A mutation may occur on one allele of one chromosome 
7 in a susceptible hematopoietic stem cell, either inherited in 
familial cases or a somatic mutation. Exposure to mutagenic 
agents may be responsible for this event in cases of second- 
ary MDSAeukemia. Imprinting has been investigated as a 
mechanism of disease; however, using RFLP analysis there 
is currently no firm evidence supporting its existence in fa- 
milial or nonfamilial  case^.^.^' Gene dosage is another expla- 
nation. In this case a critical gene for MDS on chromosome 
7 within the deleted region must show haploinsufficiency, ie, 
two copies of the gene are essential for a normal phenotype. 
Absolute levels of protein are important in certain develop- 
mental pathways and in humans chromosomal aneusomy 
resulting in hemizygosity for a particular gene may lead 
to insufficient protein and upset the homeostatic pathway? 
However, the family described show only a proportion of 
those with the inversion with the blood disorder, suggesting 
gene dosage to be an unlikely explanation. 
Our study has defined an interval within the q22.1 band 
of chromosome 7 of importance in MDS. The mapping re- 
agents and data presented here will contribute to ongoing 
studies to better define regions along 7q critical in MDS. 
The identification and characterisation of genes (including 
ASNS) within such critical regions will allow the mechanism 
of disease to be studied and may suggest alternative ap- 
proaches to the management of this malignancy. 
Fig 5. (see page 3664) flSH images: Cormids 524 and 7cl and 
YAC HSC7E783 are W l a d  with blotin a d  detected with fluorescein 
giving green signals. The chromosome 7 centromere probe is labeled 
with digoxigenin and detected with rbdamlne gMng a red rignal. 
The background staining of th. ehromoaomem is with DAW. a.ik Cor- 
mid 524 showing hybrididon at 7q22 on inversion chromosome 7 
and normal chromosome 7 of DDlO27 cell Ilne. b.1): conmid 74 show- 
ing hybridization at 7q22 on normal chromosome 7 of cell line, but 
distal hybridization on inversion chromosome 7. c.i): YAC HsC7E783 
showing split signal on inversion chromasome 7 but expectd dgnal 
on normal chromosome 7 of cell line. a.ii), b.ii), and c.ii) show hybrid- 
ization of cormids 524 and 7d  and YAC HSCIE783 mspectlvdy at 
expected position at 7q22 on both chromosomes 7 on normal mete- 
phase chromosomes. 
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Fig 5. 
2 
Patient A 
Patient B 
Patient C 
Fig 6. 
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PATIENT A 
PATIENT B 
PATIENT C 
Fig 6. (Color panels) YAC HSC7E783 and the chromosome 2 cen- 
tromere probe are labeled with biotin and detected with fluorescein 
giving green signals. The chromosome 7 centromere probe is labeled 
with digoxigenin and detected with rhodamine giving a red signal. 
The background staining of the chromosomes is with DAPI. Three 
patients with t(2;7)(pll;q22) each with a different breakpoint as de- 
fined by YAC HSC7E783. (Black and white panels) Karyotypes with 
DAPI banding corresponding to  the FISH pictures in the color panels. 
Fig 7. YAC HSC7E783 is labeled with biotin and detected with 
fluorescein giving green signals. The chromosome 7 centromere 
probe is labeled with digoxigenin and detected with rhodamine giv- 
ing a red signal. The background staining of the chromosomes is 
with DAPI. Patient with del(7q)- YAC HSC7E783 hybridizes at 7q22 
on normal chromosome with loss of signal on deletion chromosome. 
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